Amyris, Inc. (AMRS) to Release Quarterly Earnings on Wednesday
Amyris, Inc. (NASDAQ:AMRS) will be releasing its earnings data after the market closes on Wednesday, November 8th. Analysts expect Amyris to post earnings of ($0.77) per share for the quarter.
Amyris (NASDAQ:AMRS) last announced its earnings results on Thursday, August 10th. The biotechnology company reported ($1.41) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($1.06) by ($0.35). The firm had revenue of $25.68 million during the quarter, compared to analyst estimates of $23.68 million. The business’s revenue was up 167.5% on a year-over-year basis. During the same quarter last year, the firm posted ($0.06) earnings per share. On average, analysts expect Amyris to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Amyris, Inc. (NASDAQ AMRS) opened at $3.19 on Tuesday. The company has a quick ratio of 0.56, a current ratio of 0.65 and a debt-to-equity ratio of -0.76.
Several brokerages have recently issued reports on AMRS. ValuEngine upgraded Amyris from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st. Cowen and Company set a $4.00 price target on Amyris and gave the company a “hold” rating in a report on Thursday, August 17th. HC Wainwright reaffirmed a “buy” rating and issued a $15.00 price target on shares of Amyris in a report on Tuesday, September 26th. Finally, Zacks Investment Research raised shares of Amyris from a “hold” rating to a “buy” rating and set a $3.75 target price on the stock in a research note on Wednesday, October 4th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $20.69.
Amyris, Inc is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels.
Receive News & Ratings for Amyris Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amyris Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.